| |
After participating in this activity, participants should
be able to: |
 |
Define anemia and iron-deficiency anemia |
|
Describe the clinical and economic impact of anemia |
|
Review normal erythropoiesis and explain the pathophysiology of anemia for several common disease states |
|
Identify treatment options for iron-deficiency anemia |
|
Discuss the pharmacokinetics and safety of currently available IV iron preparations |
|
Assess pharmacoeconomic benefits of balancing ESA and iron therapy |
Joanna Hudson, PharmD, BCPS, FASN
Associate Professor, Department of Clinical Pharmacy
Assistant Professor, Department of Medicine (Nephrology)
The University of Tennessee
Department of Clinical Pharmacy
Memphis, TN |
|
| PHARMACIST CE INFORMATION |
HDCN is pleased to make available this web program devoted to the continuing education of pharmacists.
 |
Accreditation Information:
Medical Education Resources (MER) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. MER designates this continuing education activity for 1.0 contact hours (0.10 CEUs) of the ACPE. Universal Program Number: 816-000-06-070-H01
Statements of credit will be mailed within 4 weeks of receipt of appropriate documentation of course completion.
Release Date: February 1, 2007
Expires: January 15, 2009
There is no fee for participation in this activity.
Intended Audience: Pharmacists. Note, this program is NOT intended for physicians or nurses, and no physician CME or nursing CE credit is available.
|
|
|
| SPEAKER DISCLOSURE STATEMENT : |
Dr. Hudson is a member of the Speakers' Bureau of Watson Pharmaceuticals, Inc.
No declared off-label usage. (Always please check the official drug label for FDA-approved indications).
This CE symposium was supported by a restricted educational grant from
Watson Pharmaceuticals, Inc.
| PHARMACIST CE POLICY STATEMENTS : |
The CE policy and disclosure statements
of HDCN are listed on this page. |
|
